title: Hepatitis B reactivation during everolimus treatment.
authors: a Gustave Roussy Cancer Campus , Villejuif , France.
authors: Olivier
authors: O
authors: Mir
authors: b Institut Bergonié , Bordeaux , France.
authors: Maud
authors: M
authors: Toulmonde
authors: c Cochin Teaching Hospital, University Paris Descartes , Paris , France.
authors: Romain
authors: R
authors: Coriat
authors: d Antony Private Hospital , Antony , France.
authors: Stanislas
authors: S
authors: Ropert
authors: c Cochin Teaching Hospital, University Paris Descartes , Paris , France.
authors: Pierre
authors: P
authors: Loulergue
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000556:secondary / Q000821:virology; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D000068338:Everolimus / Q000009:adverse effects*; D005260:Female; D006509:Hepatitis B / Q000139:chemically induced* / Q000821:virology; D006515:Hepatitis B virus / Q000472:pathogenicity*; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D011379:Prognosis; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D000068338:Everolimus